Nutrien Ltd. Common Shares
Here’s whether Nutrien Ltd. Common Shares (NTR) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 40 — healthy momentum range; strong 1-year return of +11.9%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.14% over 10 days); 3-month momentum negative (-13.1%). Currently 20.8% off its 52-week high. Score: +1/7.
NTR is holding above its long-term 200-day MA ($65.70) but has slipped below the 50-day MA ($71.44), pointing to short-term weakness in an otherwise intact trend. An RSI of 40.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +11.9% compares to +22.9% for SPY (trailed the market by 11.0%). The current 20.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.